Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.

[1]  R. Schinazi,et al.  Facile purification of honokiol and its antiviral and cytotoxic properties. , 2006, Journal of medicinal chemistry.

[2]  Yeuk-Chuen Liu,et al.  Cytotoxic neolignans: an SAR study. , 2005, Bioorganic & medicinal chemistry letters.

[3]  K. Anderson,et al.  Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. , 2004, Blood.

[4]  J. Arbiser,et al.  The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. , 2004, Blood.

[5]  Y. Mitsumoto,et al.  Efficient synthesis and structure-activity relationship of honokiol, a neurotrophic biphenyl-type neolignan. , 2004, Bioorganic & medicinal chemistry letters.

[6]  Ana M. Martin Castro,et al.  Claisen rearrangement over the past nine decades. , 2004 .

[7]  T. Nakazawa,et al.  Metabolites of orally administered Magnolia officinalis extract in rats and man and its antidepressant‐like effects in mice , 2003, The Journal of pharmacy and pharmacology.

[8]  P. M. Campbell,et al.  Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo* , 2003, Journal of Biological Chemistry.

[9]  M. Otto,et al.  Antiviral Activities and Cellular Toxicities of Modified 2′,3′-Dideoxy-2′,3′-Didehydrocytidine Analogues , 2002, Antimicrobial Agents and Chemotherapy.

[10]  C. Der,et al.  Ras Inactivation of the Retinoblastoma Pathway by Distinct Mechanisms in NIH 3T3 Fibroblast and RIE-1 Epithelial Cells* , 2000, The Journal of Biological Chemistry.

[11]  D. Wiederschain,et al.  Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. , 2000, The American journal of pathology.

[12]  R. D'Amato,et al.  The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice. , 1999, Journal of the American Academy of Dermatology.

[13]  S. Oldham,et al.  Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Lo,et al.  Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. , 1994, Biochemical pharmacology.

[15]  R. Schinazi,et al.  Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1 , 1990, Antimicrobial Agents and Chemotherapy.

[16]  C. Teng,et al.  Two antiplatelet agents from Magnolia officinalis. , 1988, Thrombosis research.

[17]  S. Weintraub,et al.  Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine. , 1998, Journal of natural products.

[18]  C. C. Chen,et al.  EDRF-release and Ca+(+)-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. , 1990, Life sciences.